BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 1840099)

  • 1. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
    Suzuki K; Vanier MT
    Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.
    Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K
    Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
    Navon R
    Dev Neurosci; 1991; 13(4-5):295-8. PubMed ID: 1840100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical consequences of mutations causing the GM2 gangliosidoses.
    Mahuran DJ
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
    Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
    Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
    Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
    J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal.
    dos Santos MR; Tanaka A; sá Miranda MC; Ribeiro MG; Maia M; Suzuki K
    Am J Hum Genet; 1991 Oct; 49(4):886-90. PubMed ID: 1832817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tay-Sachs disease].
    Tanaka A
    Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
    Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
    Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for the "DN allele" (G533-greater than A) of the beta-hexosaminidase alpha subunit gene identified by direct DNA sequencing in a family with the B1 variant of GM2-gangliosidosis.
    Whitley CB; Anderson RA; McIvor RS
    Neuropediatrics; 1992 Apr; 23(2):96-101. PubMed ID: 1318511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
    Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
    Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
    Paw BH; Kaback MM; Neufeld EF
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical aspects of adult hexosaminidase deficiencies.
    Federico A; Palmeri S; Malandrini A; Fabrizi G; Mondelli M; Guazzi GC
    Dev Neurosci; 1991; 13(4-5):280-7. PubMed ID: 1840098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma G
    Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
    Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of GM2-gangliosidosis B1 variant.
    Lemos M; Pinto R; Ribeiro G; Ribeiro H; Lopes L; Sá Miranda MC
    Prenat Diagn; 1995 Jun; 15(6):585-8. PubMed ID: 7659693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.
    Ribeiro MG; Sonin T; Pinto RA; Fontes A; Ribeiro H; Pinto E; Palmeira MM; Sá Miranda MC
    J Med Genet; 1996 Apr; 33(4):341-3. PubMed ID: 8730294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
    Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
    Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.